{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T05:21:25Z","timestamp":1772515285164,"version":"3.50.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["A\/RD\/RP-2\/Pharmacy\/2017-18\/277"],"award-info":[{"award-number":["A\/RD\/RP-2\/Pharmacy\/2017-18\/277"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSAMC"],"published-print":{"date-parts":[[2020,3,3]]},"abstract":"<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>In the current study, the synthesis, characterization, and neuropharmacology\nof quinazolinone tethered with aromatic (3a-3i) and heteroaromatic substitution (3j, 3k, and 3l) as\neffective anxiolytic agents are reported.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Anxiety and depression are often comorbid with neurological as well as other\nmedical maladies. Clinically known anxiolytics (Benzodiazepines) are accompanied by untoward\nsedation and other CNS depressive actions. The quinazolinone moiety is a privileged pharmacophore\nwith a wide pharmacological spectrum. Herein, the synthesis, characterization, and neuropharmacological\nevaluation of some 2-substituted quinazolinone derivatives are reported.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The synthesized compounds were characterized using 1H-NMR and TLC analysis. Behavioral\nanalysis was performed using EPM (Elevated Plus Maze), OFT (Open Field Test), PIST\n(Pentobarbital Induced Sleep Test), FST (Forced Swim Test) and PCPA (p-chlorophenyl alanine)\nbioassay. To further justify the therapeutic claim, systemic and neurotoxicological analysis of the\nmost potent members of the series was performed using OECD mandated protocols. The studies\nshowed that the compounds had a wide therapeutic window with &gt;1000 mg\/kg and &gt;500 mg\/kg\nLD50 and NOAEL, respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The compounds with an electronegative group in the quinazolinone nucleus (3f, 3e, 3d,\nand 3c) induced anxiolysis devoid of sedative adverse reaction. Besides, anti-depressant efficacy\nof 3f, 3e, 3d, and 3c observed in rodents was a result of a decrease in anxiety level. It was found\nthat the neurotoxicology of the potent members (3f, 3e, 3d, and 3c) advocated their wide therapeutic\nwindow with &gt;1000 mg\/kg LD50 and &gt;5000 mg\/kg NOAEL.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our findings of behavioral bioassays revealed that inducing an electronegative\ngroup into the quinazolinone nucleus yielded the most potent members of the series (3f, 3e, 3d,\nand 3c). The said compounds were found to produce anxiolysis and anti-depressive action without\nsedative-hypnotic side effects in rodent models. In summary, it can be stated that extending the\nstudies in a clinical setting would furbish the contours of current anxiolytic therapy, especially in\nanxiety comorbid with medical maladies.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871524920666191220112545","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T08:07:39Z","timestamp":1576829259000},"page":"26-40","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Electronegativity in Substituted-4(H)-quinazolinones Causes Anxiolysis without a Sedative-hypnotic Adverse Reaction in Female Wistar Rats"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6140-5218","authenticated-orcid":true,"given":"Shweta","family":"Mishra","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dr. Harisingh Gour Viswavidyalaya, Sagar, MP, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debashree","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dr. Harisingh Gour Viswavidyalaya, Sagar, MP, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5190-8236","authenticated-orcid":true,"given":"Adarsh","family":"Sahu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dr. Harisingh Gour Viswavidyalaya, Sagar, MP, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekta","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dr. Harisingh Gour Viswavidyalaya, Sagar, MP, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2986-8578","authenticated-orcid":true,"given":"Shailendra","family":"Patil","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Medical Science and Paramedical Sciences, Swami Vivekanand University, Sagar, MP, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram Kishore","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dr. Harisingh Gour Viswavidyalaya, Sagar, MP, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7180-379X","authenticated-orcid":true,"given":"Asmita","family":"Gajbhiye","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dr. Harisingh Gour Viswavidyalaya, Sagar, MP, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Central Nervous System Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/177659","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T07:34:11Z","timestamp":1583307251000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/177659\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871524920666191220112545","relation":{},"ISSN":["1871-5249"],"issn-type":[{"value":"1871-5249","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-10-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}